SEC Form 4 · accession 0000914760-15-000277
Akari Therapeutics Plc · AKTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clive Richardson
Officer — COO · Director
Period of report
Sep 21, 2015
Accepted (ET)
Sep 23, 2015 · 10:43 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001541157
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options (right to buy) | $0.3221 | Sep 21, 2015 | A | 16,271,850 | A | Sep 21, 2016 | Sep 21, 2025 | Ordinary Shares | 16,271,850 | 16,271,850 | D |